Regional Block of the Nose for Hypotensive Anaesthesia in Septo-rhinoplasty

Efficacy of Regional Block of the Nose in Achieving Hypotensive Anaesthesia in Septo-rhinoplasty Surgery

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03774693

Enrollment

Registered

2018-12-13

Start date

2018-11-28

Completion date

2019-03-31

Last updated

2018-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotensive Anesthesia

Brief summary

Septorhinoplasty is a cosmetic surgery that many people are choosing to undergo. It can be done under general anesthesia, twilight anesthesia or regional anesthesia. Controlled hypotensive anesthesia is required to minimize bruising, swelling, and bleeding that reduces visibility in the operative field and hence satisfactory surgical outcome. The goal of our study to prove that regional block of the nose provides efficient hypotensive anesthesia

Interventions

OTHERGeneral anesthesia with fentanyl boluses

Patients will receive general anesthesia with Fentanyl boluses of 0.5 mcg.Kg-1 given to maintain MAP between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1

PROCEDURERegional block

Patients will receive trans-oral bilateral sphenopalatine ganglion block and trans-oral bilateral infraorbital nerve block.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

* American Society of Anesthesiologists (ASA) physical status I-II * Scheduled for elective septo-rhinoplasty surgery

Exclusion criteria

* Patients with hypertension or coronary artery disease, * Patients with renal, hepatic or cerebral insufficiency, * Patients with coagulopathy or receiving drugs influencing blood coagulation, * Patients with known sensitivity to any of the study drug

Design outcomes

Primary

Measure	Time frame	Description
Hypotensive anesthesia	Intraoperative	Measurement of Mean arterial blood pressure
Requirements of Fentanyl	Intraoperative	Assessment of intraoperative fentanyl doses of \[Fentanyl boluses of 0.5 mcg.Kg-1 will be given to maintain mean arterial pressure (MAP) between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1\]

Secondary

Measure	Time frame	Description
Average category scale (ACS)	Intraoperative	The surgeon will be asked, at the end of surgery, to assess bleeding in the surgical field using the average category scale 0-5 scale where \[0=No bleeding and5=Severe bleeding\]

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026